Scientists at the Technische Universität Dresden/Germany are significantly involved in a European research project entitled “BioSim“ which aims at utilising biosimulation as a new tool in drug development. The use of computer simulations will provide more objective data which helps to develop drug compounds more effectively and to reduce investment in drug development drastically. Above all the number of animal tests as well as clinical studies with volunteers will decrease substantially.
“We intend to translate the existing knowledge of drug metabolism and the operating modes of several organs into mathematical models. These serve to perform complex computer simulations of the involved biochemical processes”, says assistant professor Dr Martin Bertau, biochemist at the Department of Chemistry and Food Chemistry at the Technische Universität Dresden.
The highly ambitious scientific “Network of excellence“ – also called “BioSim” – has been funded with 10.7 million euros by the European Union for a five year period since December 2004 and brings together internationally leading European research groups in the fields of life sciences, medicine and mathematics. The activities are coordinated by Professor Erik Mosekilde, Institute of Physics at the Danish University of Technology in Kgs. Lyngby. On the part of the pharmaceutical industry Apogepha Arzneimittel GmbH is involved in Dresden. The network is completed by European regulatory agencies as well as the European Federation of Pharmaceutical Sciences.
PD Dr Martin Bertau | alfa
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences